SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.04+2.6%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: zurdo who wrote (2791)5/22/1998 10:18:00 PM
From: Paul Tran  Read Replies (2) of 9523
 
Maybe a hedge on PFE with VVUS, a repost from other thread.

Fair value of Vivus is over $20.00/share.

The following events should help at least double our share price.

1)FDA approval of new plant--to be announced no later than Monday June first.

2)Increasing script numbers starting week ending May 15.

3)Viagra hype coming to an end. The media hyped it and now they will bash it which is
typical of great American journalism.

4)Short interest still ridiculously high. Maybe the shorts will start thinking about
covering when we hit 15 and they can then cover us to 20+.

5)A lot of money is leaving big name computer/chip stocks and fund managers are
now looking for VALUE. Vivus is VALUE at current prices.

6)Rumors have been hot about Astra or Janssen buying out Vivus.
If this is so you can expect at least a 100% gain the day the announcement is made.

7)Over the last year international sales were not a consideration in the stock price but
now they should be. Vivus claims that it is shipping out all product it can make. Vivus
did not expect as great of a demand as is presently occuring in England. Lower
demand in the USA during the Viagra hype has actually been a blessing for
Vivus--they are able to ship extra product to Astra for sale in England which would
have been in short supply if more MUSE was needed domestically. England will not
have a supply shortage which adversely effected MUSE sales in the USA when supply
could not meet demand.

To those waiting on the sidelines wondering what to do all I can say is jump in on
Tuesday while the price is still low. The media exposure this Friday alone has been
very good for Vivus. Vivus is getting free media exposure for MUSE as a safe local
alternative to the dangers of Viagra. Just watch the news this weekend for more free
MUSE press.

Maybe Jay Leno will crack a few more MUSE jokes like last time which popped us
to $15.00+ in a few trading days.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext